
Autologous PRP & dextrose prolotherapy equally effective in recalcitrant plantar fasciitis

Autologous PRP & dextrose prolotherapy equally effective in recalcitrant plantar fasciitis
Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis
PM R. 2014 Feb;6(2):152-8. doi: 10.1016/j.pmrj.2013.07.003.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
21 patients diagnosed with chronic recalcitrant plantar fasciitis were randomized to receive either dextrose prolotherapy (DP) or autologous platelet-rich plasma (PRP) injection therapy. The purpose was to evaluate the efficacies of these treatments and additionally, to assess whether one is more effective. Results at 28 weeks indicated that both treatments significantly improved total Foot Functi...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.